Evidence mapPaperPMID 37628583Full record

ArticleGenes2023

Impaired Repopulating Ability of

Takahiro Sano, Koki Ueda, Keiji Minakawa, Tsutomu Mori, Yuko Hashimoto, Haruhiko Koseki, Yasuchika Takeishi, Kazuhiko Ikeda, Takayuki Ikezoe

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. UHRF2 accumulates in early GCell cycle (Georgetown, Tex.) · 2024
    Article
  3. E3 Ubiquitin LigaseInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Takahiro SanoDepartment of Hematology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
Koki UedaDepartment of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.ORCID 0000-0002-6964-7035
Keiji MinakawaDepartment of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
Tsutomu MoriDepartment of Human Life Sciences; Fukushima Medical University School of Nursing, Fukushima 960-1295, Japan.
Yuko HashimotoDepartment of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
Haruhiko KosekiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Wako 351-0198, Japan.
Yasuchika TakeishiDepartment of Cardiovascular Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
Kazuhiko IkedaDepartment of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.ORCID 0000-0002-5269-269X
Takayuki IkezoeDepartment of Hematology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.ORCID 0000-0002-7858-278X
Fukushima Medical University · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UHRF proteins catalyze the ubiquitination of target proteins and are involved in regulating gene expression. Some studies reported a reduced expression of UHRF2 in acute leukemia cells, but the role of UHRF2 in hematopoiesis remains unknown. Here, we generated

Indexed as

B-LymphocytesHematopoietic Stem CellsAnimalsBiological AssayCatalysisDown-RegulationMicehematopoiesishematopoietic stem and progenitor cellsUHRF2

Identifiers

PMID37628583
PMCPMC10454722
OpenAlexW4385309676

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.